Healthy Adult ParticipantsDigital healthHealthy volunteersDevice
What this study is
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
What's being tested
- eWave Patch
Intervention · DEVICE
This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.
Study details
- Official title
- WearLinq eWave Patch Study
- Sponsor
- Wearlinq
- Conditions
- Healthy Adult Participants · Heart Disease · Arrythmia · Cardiac
- Enrolling
- 500 people
- Starts
- 2026-07-06
- Est. completion
- 2027-07-31
- Design
- Open-label, non-randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Adult >18 years old and able to consent
- Capable of using a smartphone app
- Willing to shave patch area if needed
You can't join if
- Planning to undergo an MRI during the study period
- Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results
- Presence of pacemaker, ICD or other implanted electronic devices
- Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum)
- Pregnant or intending to become pregnant during the course of the study
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openABio Clinical Research Partners
New London, North Carolina, United States
- Andrea Brown, MS · Contact408-881-2611wearlinqstudy@abioclinical.com
Recruiting
Study team
Sponsor
Wearlinq
Study ID CLN 0001
Study director
Chris Daniel
WearLinq, Inc.
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.